15 Current news of Millipore

rss

Merck KGaA Completes Millipore Acquisition and Launches New Merck Millipore Division

Merck Chemicals now comprises two new divisions: Merck Millipore and Performance Materials

07-16-2010

Merck KGaA announced the successful completion of its acquisition of Millipore Corporation, a leading Life Science company based in Billerica, Massachusetts, USA, for an aggregate purchase price including debt and cash of approximately EUR 5.2 billion (US$ 7.0 billion). Merck agreed to ...

more

Millipore Expands BioPharma CRO Services in Europe

05-25-2010

Millipore Corporation has moved its European BioPharma Services unit to new, expanded facilities to accommodate strong growth in the biotechnology sector. The new facilities are located in Milton Park, near Didcot in Oxfordshire, England. Millipore’s BioPharma Services unit is the first ...

more

Merck KGaA to acquire all outstanding Millipore shares for US$ 107 per share in cash

Combination will create a € 2.1 billion (US$ 2.9 billion) partner for the Life Science sector and transform Merck Chemicals

03-02-2010

Merck KGaA and Millipore Corporation announced that they have entered into a definitive agreement under which Merck KGaA will acquire all outstanding shares of common stock of Millipore, for US$ 107 per share in cash, or a total transaction value, including net debt, of approximately € 5.3 ...

more

Millipore Names New VP of Life Science Business Unit

John Sweeney to focus on technology development and partnerships

08-14-2009

Millipore Corporation announced the appointment of John Sweeney as Vice President of Millipore’s Life Science SBU. Most recently, Sweeney served as Vice President of Strategy and Marketing services for Millipore’s Bioscience Division. Sweeney joined Millipore in 2003 as Director of Strategy ...

more

Millipore Expands Drug Discovery and Development Services with BioAnaLab Acquisition

Acquisition extends Millipore’s biopharmaceutical services offering to European market

08-11-2009

Millipore Corporation announced it has acquired BioAnaLab, a European-based services provider that specializes in the analysis of biologic drugs and vaccines. The transaction enables Millipore to expand its biopharmaceutical services business into Europe and further strengthens its position ...

more

Millipore Corporation Opens New Facility in Singapore

02-18-2009

Millipore Corporation opened its state-of-the-art Biomanufacturing Sciences and Training Center (BSTC) in Singapore. The 8,000 square foot facility will provide support and technical service to Millipore’s biopharmaceutical customers who have operations throughout Asia. “When many of our ...

more

Millipore Forms Collaboration with Agilent Technologies to Expand Capabilities in Epigenetics Research Market

09-05-2008

Millipore Corporation and Agilent Technologies Inc. announced they have formed a collaboration to develop ChIP (chromatin immunoprecipitation) kits for the fast-growing epigenetics research market. The kits will be designed to improve protein researchers’ productivity and simplify the way ...

more

Millipore Corporation's re-branding underscores expanded capabilities and partnership with customers

Millipore Foundation awards $500,000 research gift to the Harvard Stem Cell Institute

09-17-2007

Millipore Corporation unveiled its new brand initiative and visual identity. The re-branding affirms Millipore's transformation from high performance filtration systems provider to Life Science corporation, focused on delivering the pioneering technologies and deep expertise necessary for ...

more

Millipore Becomes First Company to Embed RFID Technology in Filtration Products Used for Biopharmaceutical Manufacturing

04-17-2007

Millipore Corporation announced that it is the first company to successfully integrate Radio Frequency Identification (RFID) technology with filtration products used to manufacture biopharmaceutical drugs. The new RFID capability will be branded as SMART Technology and will be introduced at ...

more

Millipore and Stem Cell Sciences To Provide Human Embryonic Stem Cell Media

10-27-2006

Millipore Corporation and Stem Cell Sciences (SCS) announced an exclusive license for Millipore to develop and market SCS' serum free media for the growth of human embryonic stem cells (hESCs). According to the company, the defined media will be the first product available in the industry ...

more

Page 1 From 2
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE